 PARIS CAMBRIDGE, Mass.--BUSINESS WIRE--Regulatory News: NANOBIOTIX Euronext: NANO NASDAQ: NBTX the Company, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that the Companys leadership will participate in three upcoming, virtual investor conferences in January 2022. Event Details: Oddo BHF Forum 2022 Date: January 6-11, 2022 Format: Virtual one-on-one meetings with investor 